Last $48.50 USD
Change Today -0.06 / -0.12%
Volume 789.5K
As of 8:10 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

arthrocare corp (ARTC) Snapshot

Open
$48.50
Previous Close
$48.56
Day High
$48.56
Day Low
$48.49
52 Week High
01/8/14 - $49.95
52 Week Low
09/3/13 - $31.56
Market Cap
1.7B
Average Volume 10 Days
431.0K
EPS TTM
$1.51
Shares Outstanding
34.4M
EX-Date
--
P/E TM
32.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for ARTHROCARE CORP (ARTC)

arthrocare corp (ARTC) Related Businessweek News

No Related Businessweek News Found

arthrocare corp (ARTC) Details

ArthroCare Corporation, a medical device company, develops, manufactures, and markets surgical products based on its Coblation technology in the Americas and internationally. It offers sports medicine products, including Coblation Wands that features disposable energy-based surgical wands for single patient use to treat shoulder, knee, hip, foot, ankle, elbow, and wrist injuries; and soft-tissue fixation products, such as knotless and traditional anchors for rotator cuff and labrum repairs in the shoulder and hip; screws for ligament reconstruction in the knee; and arthroscopic suture passers, as well as reusable hand-held instruments, procedural kits, and accessories. The company also provides ear nose and throat products consisting of suction wands, channeling wands, and excision wands; ENTact septal stapler for reattaching nasal mucosal flaps; SerpENT articulating instruments, which include cutting and grasping tools; and Ventera sinus dilation systems. In addition, it offers carboxymethyl-cellulose based packing and tamponade products, such as Rapid Rhino product line; dissolvable Stammberger sinus dressing and sinu knits to control minor bleeding, facilitate epithelial healing, and preserve the spatial integrity of the sinus area; and epistaxis balloon tamponade products for the hospital emergency room environment to control severe nosebleeds. Further, the company provides SpineWand devices to treat soft tissue conditions in the spine; Plasma Disc Decompression SpineWands for treating contained herniated discs; Cavity SpineWand to reduce the size of malignant lesions in the vertebrae of patients suffering from spinal compression fractures; and WoundWand for wound debridement and wound cleansing by removal of necrotic tissue. The company sells its products to surgeons and specialized medical professionals through sales representatives, and independent sales agents and distributors. ArthroCare Corporation was founded in 1993 and is headquartered in Austin, Texas.

1,840 Employees
Last Reported Date: 02/13/14
Founded in 1993

arthrocare corp (ARTC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $564.8K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $370.2K
Senior Vice President and General Manager of ...
Total Annual Compensation: $306.2K
Chief Technical Officer and Senior Vice Presi...
Total Annual Compensation: $285.1K
Senior Vice President of Global Markets & Sal...
Total Annual Compensation: $308.6K
Compensation as of Fiscal Year 2012.

arthrocare corp (ARTC) Key Developments

ArthroCare Corporation Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013

ArthroCare Corporation announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company reported total revenues of $101,708,000 compared to $96,936,000 a year ago. Income from operations was $16,801,000 compared to $15,138,000 a year ago. Income from continuing operations before income taxes was $15,849,000 compared to $15,289,000 a year ago. Net income available to common stockholders was $10,431,000 or $0.30 per basic and diluted share compared to $10,262,000 or $0.30 per basic and diluted share a year ago. In the third quarter of 2013 Adjusted income from operations was $15.9 million compared to $15.8 million in the same quarter of 2012. For the year, the company reported total revenues of $377,989,000 compared to $368,454,000 a year ago. Income from operations was $31,965,000 compared to $64,134,000 a year ago. Income from continuing operations before income taxes was $31,115,000 compared to $63,707,000 a year ago. Net income available to common stockholders was $22,321,000 or $0.64 per diluted share compared to $42,803,000 or $1.25 per diluted share a year ago. Cash flows provided by operating activities for the year ended December 31, 2013 was $72.4 million compared to cash provided by operations of $6.3 million for the year ended December 31, 2012 which included the payment of $74 million required to settle the private securities class actions against the company. Adjusted for this payment, cash flows provided by operating activities would have been $80.3 million for the year ended 2012.

An Investor Files Lawsuit Against in ArthroCare Corp

An investor in ArthroCare Corp. has filed a lawsuit against the company in an attempt to halt its proposed buyout by Smith & Nephew PLC. The Shareholders Foundation announced the plaintiff in the case alleges the per-share purchase price of $48.25 agreed upon by ArthroCare's board of directors was too low and undervalues the company.

ArthroCare Corporation, Smith & Nephew plc - M&A Call

Smith & Nephew plc to discuss on execution of a definitive agreement to acquire ArthroCare Corp

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARTC:US $48.50 USD -0.06

ARTC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cyberonics Inc $61.25 USD -0.77
ICU Medical Inc $56.38 USD -0.57
Thoratec Corp $33.92 USD +0.24
Tornier NV $18.24 USD -0.26
Wright Medical Group Inc $28.39 USD +0.59
View Industry Companies
 

Industry Analysis

ARTC

Industry Average

Valuation ARTC Industry Range
Price/Earnings 75.9x
Price/Sales 3.7x
Price/Book 3.4x
Price/Cash Flow 59.5x
TEV/Sales 3.6x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARTHROCARE CORP, please visit www.arthrocare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.